What is myrcene?

Myrcene, often called beta-myrcene, is a monoterpene with the formula C₁₀H₁₆. Chemical identity tells you which molecule a report is describing. It does not tell you whether a particular amount will produce a noticeable effect.

It is useful to separate three questions when reading about any terpene: What is the compound? What did an experiment measure? Does that experiment resemble the product or situation being discussed? An answer to the first question cannot replace evidence for the other two.

Sources: Myrcene, CID 31253 (2026)

Does myrcene make you sleepy?

The often-repeated claim that myrcene increases sleep around 2.6-fold comes from a 2002 mouse experiment involving drug-induced sleep. It was not a measurement of natural sleep in people. Researchers also assessed movement and motor coordination after injected compounds.

The same abstract reported no anxiety-reducing effect, with anxiety-like effects at higher experimental exposures. Keeping that finding beside the sedation result avoids turning a mixed set of observations into a simple calming promise. Our assessment of this paper is limited to its abstract.

Sources: Central effects of citral, myrcene and limonene (abstract reviewed) (2002)

A newer inhalation study is still an animal study

An October 2026 paper investigated inhaled beta-myrcene in mice with a chemically induced insomnia model. The abstract reported a shorter time to fall asleep and longer sleep duration in an amobarbital sleep test, alongside changes in measured signaling and gut bacteria.

Changing the exposure route makes this a useful research development, but it does not turn a mouse experiment into a human insomnia trial. The abstract describes associations involving several biological measurements; it does not establish a clinically useful mechanism in people. We reviewed the abstract, not the full methods or underlying data.

Sources: Inhaled beta-myrcene in a mouse model of insomnia (abstract reviewed) (2026)

What the human sleep trial actually tested

A 2025 randomized crossover trial compared CBD plus eight terpenes, including myrcene, with placebo. Of 125 randomized participants, 62 completed the study and 56 complete datasets entered the final analysis. Sleep was measured with a wrist-worn tracker rather than a full overnight sleep-laboratory assessment.

The mixture increased the proportion of time classified as slow-wave plus REM sleep by 1.3 percentage points on average. Total sleep time did not improve, and self-reported sleep improvements were not statistically significant. No adverse events were reported.

Many participants leaving the study, a small average difference and the mixed formulation limit interpretation. The study was funded by Defined Research Inc., and authors reported company equity or stock options. It cannot establish that myrcene caused the observed difference.

Sources: Effects of a cannabidiol/terpene formulation on sleep in individuals with insomnia (2025)

Compare the question, not just the headline

These studies ask different questions. A finding about an animal sleep test and a finding about a human mixture should not be counted as two independent demonstrations that isolated myrcene treats insomnia.

What each study can and cannot tell us
StudyTestedMain boundary
2002 mouse experimentInjected compounds and drug-induced sleepNot natural human sleep
2026 mouse experimentInhaled beta-myrcene in an induced modelHuman benefit remains untested by this experiment
2025 human trialCBD plus eight terpenesCannot isolate myrcene’s contribution

Sources: Central effects of citral, myrcene and limonene (abstract reviewed) (2002); Inhaled beta-myrcene in a mouse model of insomnia (abstract reviewed) (2026); Effects of a cannabidiol/terpene formulation on sleep in individuals with insomnia (2025)

Was myrcene banned by the FDA?

In 2018, the FDA removed authorization for synthetic myrcene as a food flavoring under the Delaney Clause after animal cancer findings. The agency also said its assessment did not identify a public-health risk at the very low exposures associated with the intended food uses.

The action did not change the status of foods containing natural counterparts or flavorings extracted from those foods. It was not a blanket ban on plants containing myrcene.

Equally, a statement about food exposure does not establish that concentrated inhalation is safe. Keep the regulatory decision, the animal findings and the exposure being considered separate.

Sources: FDA removes seven synthetic flavoring substances from food additives list (2018)

What a myrcene percentage can tell you

On a laboratory report, a myrcene result describes a measured concentration in the tested sample. Check the batch identifier, units and reporting notes before comparing it with another report. Product mass percentage and the share of a listed terpene total use different denominators.

A higher number is not, by itself, a validated sleepiness score. The studies discussed here do not establish a universal myrcene percentage that predicts how a person will feel. A missing result, ND or below-LOQ entry should not be silently replaced with zero.

For an example you can work through, start with the terpene profile guide. For broader sleep research, use the separate cannabis-and-sleep review. These answer different questions without treating a terpene panel as a treatment plan.

Sources: Understanding Your Hemp and Cannabis COAs (2020); Converting Potency from mg/g to % (undated; accessed October 2026) (2026); Central effects of citral, myrcene and limonene (abstract reviewed) (2002); Effects of a cannabidiol/terpene formulation on sleep in individuals with insomnia (2025)